FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of pharmaceutics and medicine and deals with method of treating formation of biofilms P. Aeruginosa in patient or method of treating chronic infection P. Aeruginosa in patient by introduction of combination, including (a) 4-[3,5-bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]benzoic acid or its pharmaceutically acceptable salt and (b) antibiotic, selected from group, including gentamicin, amikacin, tobramycin, ciprofloxacin, levofloxacin, cefrazidime, cefepime, cefpirome, piperacillin, ticarcillin, meropenem, imipenem, polymyxin B, colistin and azreonam.
EFFECT: method ensures high treatment efficiency.
10 cl, 5 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF TREATING PULMONARY BACTERIAL INFECTION WITH APPLICATION OF FLUOROQUINOLONES | 2010 |
|
RU2535056C2 |
| COMPOSITION COMPRISING AN ANTIBIOTIC AND A DISPERSING AGENT OR AN ANTI-ADHESIVE AGENT | 2011 |
|
RU2739249C2 |
| COMPOSITION COMPRISING AN ANTIBIOTIC AND A DISPERSANT OR AN ANTI-ADHESIVE AGENT | 2011 |
|
RU2607660C2 |
| INHIBITION OF BIOFILM ORGANISMS | 2010 |
|
RU2548786C2 |
| COMBINED THERAPIES | 2016 |
|
RU2725800C2 |
| USING ALGINATE OLIGOMERS IN BIOFILM CONTROL | 2008 |
|
RU2527894C2 |
| METHOD FOR SIMULATING BACTERIAL INFECTION WITH UNDERLYING BURN INJURY | 2013 |
|
RU2530564C1 |
| METHOD OF DETERMINING NONSPECIFIC RESISTANCE OF PATHOGENIC MICROORGANISMS TO ANTIBIOTICS BASED ON MEASURING CATALYTIC ACTIVITY OF PHOSPHODIESTERASES CLEAVING CYCLIC DIGUANOSINE MONOPHOSPHATE | 2012 |
|
RU2518249C1 |
| ANTIMICROBIAL COMPOSITIONS | 2013 |
|
RU2694758C2 |
| SOLVATING SYSTEM AND HERMETIC FOR MEDICAL APPLICATION | 2007 |
|
RU2418574C2 |
